Chinese scientists devise a nanoparticle based vehicleBSA bureau (press release)A team of scientists from National Center for NanoScience and Technology, Beijing, China, in cooperation with medical scientists in Japan and China, have developed a gold-n… Continue reading
Metastatic Melanoma Patients May Benefit From Beta BlockersCancer NetworkBeta blockers appear to affect immune cells and improve immune function, and now investigators are reporting that beta blockers may play an important role in boosting immunotherap… Continue reading
AnGes Submits Application for Marketing Approval to PMDA for HGF gene therapy for Critical Limb IschemiaGlobeNewswire (press release)TOKYO, Jan. 23, 2018 (GLOBE NEWSWIRE) — AnGes, Inc., a biopharmaceutical company focused on developing innovative gene… Continue reading
Dope Magazine |
Singapore Announces Synthetic Medicinal Cannabinoids Research
Dope Magazine Singapore Announces Synthetic Medicinal Cannabinoids Research The five-year program announced by Singapore’s National Research Foundation (NRF) is part of a $25 million-dollar program targeting Synthetic Biology Research Development. The program will … |
FiercePharma |
Vaccine Fails to Help CMV-Positive Stem–Cell Recipients
Managed Care magazine ASP0113 (Astellas Pharma Inc./ Vical Incorporated), an investigational DNA vaccine being developed for cytomegalovirus (CMV)-seropositive hematopoietic stem cell transplant recipients, did not significantly improve overall mortality and CMV end-organ … Vical’s Astellas-partnered CMV vaccine falls short again, this time in stem cell transplant recipientsFiercePharma CMV Vaccine Falls Short in Phase III TrialOncLive |